Irinotecan
Irinotecan Hydrochloride Injection, USP is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
For indications, dosing and other information, please refer to the prescribing information.
Fully Accredited Distributor
BDI Pharma is a Verified-Accredited Wholesale Distributor and a member of HISCI. Always rest assured your product is being handled with the utmost care and professionalism.
For the FDA Wholesale Distributor License Reporting Site, click here.
Contact Us
1-800-948-9834
BDI Pharma, Inc. Headquarters
120 Research Drive, Columbia, SC, 29203
120 Research Drive, Columbia, SC, 29203
